Posted: October 2017
At the upcoming IASLC WCLC 2017 Conference, Co-Presidents Hisao Asamura, MD, and Keunchil Park, MD, PhD, will welcome delegates from more than 100 countries who will gather to witness and discuss the latest developments in thoracic malignancy research.
The WCLC 2017 motto “Synergy to Conquer Lung Cancer” captures the collaborative spirit of the conference, which will be both a scientific and educational event.
The world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals, as well as patients.
In response to the rapid advancement of the science of lung cancer, the IASLC has decided to hold the World Conferences annually. The IASLC WCLC in Yokohama will be the second of the yearly Conferences, following the IASLC World Conference in Vienna, Austria, in 2016.
Under Dr. Asamura and Dr. Park’s leadership, the latest research will be presented in the following areas:
• Advanced NSCLC
• Chemotherapy/Targeted Therapy
• Clinical Design, Statistics and Clinical Trials
• Early Stage NSCLC
• Epidemiology/Primary Prevention/ Tobacco Control and Cessation
• Immunology and Immunotherapy
• Locally Advanced NSCLC
• Nursing/Palliative Care/Ethics
• Patient Advocacy
• SCLC/Neuroendocrine Tumors
• Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
In addition, the conference program includes research presentations on Clinical Trials in Progress; Pro-Con sessions for various controversial issues; Ground Rounds; and Meet-the-Expert sessions.
At the conference, please keep upto- date by reading synopses of presented studies in IASLC WCLC Daily News, the onsite meeting newspaper. Also, look for highlights from the conference in the December 2017 issue of IASLC Lung Cancer News. ✦